156 related articles for article (PubMed ID: 33676446)
21. The impact of depression on adherence to organized and opportunistic breast cancer screening.
Montagna G; Schneeberger AR; Rossi L; Reina H; Schwab FD; Schoetzau A; Eichholzer M; Pagani O; Weber WP; Kurzeder C; Güth U; Huber CG
Eur J Cancer Prev; 2020 Jan; 29(1):53-59. PubMed ID: 30998527
[TBL] [Abstract][Full Text] [Related]
22. Trends in advanced breast cancer incidence rates after implementation of a mammography screening program in a German population.
Simbrich A; Wellmann I; Heidrich J; Heidinger O; Hense HW
Cancer Epidemiol; 2016 Oct; 44():44-51. PubMed ID: 27470937
[TBL] [Abstract][Full Text] [Related]
23. Is the incidence of advanced-stage breast cancer affected by whether women attend a steady-state screening program?
de Munck L; Fracheboud J; de Bock GH; den Heeten GJ; Siesling S; Broeders MJM
Int J Cancer; 2018 Aug; 143(4):842-850. PubMed ID: 29574967
[TBL] [Abstract][Full Text] [Related]
24. Do screen-detected breast cancers have positive margins less often than clinically detected breast cancers?
de Munck L; Siesling S; Bart J; Menke-Pluijmers MB; Otter R; Willemse PH
Eur J Cancer Prev; 2013 Sep; 22(5):398-403. PubMed ID: 23492953
[TBL] [Abstract][Full Text] [Related]
25. Trends in surgery for screen-detected and interval breast cancers in a national screening programme.
Nederend J; Duijm LE; Louwman MW; Roumen RM; Jansen FH; Voogd AC
Br J Surg; 2014 Jul; 101(8):949-58. PubMed ID: 24828281
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of organised versus opportunistic mammography screening.
Bulliard JL; Ducros C; Jemelin C; Arzel B; Fioretta G; Levi F
Ann Oncol; 2009 Jul; 20(7):1199-202. PubMed ID: 19282467
[TBL] [Abstract][Full Text] [Related]
27. Organised population-based programmes and change in socioeconomic inequalities in mammography screening: A 1992-2012 nationwide quasi-experimental study.
Cullati S; von Arx M; Courvoisier DS; Sandoval JL; Manor O; Burton-Jeangros C; Bouchardy C; Guessous I
Prev Med; 2018 Nov; 116():19-26. PubMed ID: 30145347
[TBL] [Abstract][Full Text] [Related]
28. Are breast cancer screening programmes increasing rates of mastectomy? Observational study.
Paci E; Duffy SW; Giorgi D; Zappa M; Crocetti E; Vezzosi V; Bianchi S; Cataliotti L; del Turco MR
BMJ; 2002 Aug; 325(7361):418. PubMed ID: 12193357
[No Abstract] [Full Text] [Related]
29. Digital mammography screening in Germany: Impact of age and histological subtype on program sensitivity.
Heidinger O; Heidrich J; Batzler WU; Krieg V; Weigel S; Heindel W; Hense HW
Breast; 2015 Jun; 24(3):191-6. PubMed ID: 25687106
[TBL] [Abstract][Full Text] [Related]
30. [Study of diagnostic features, health care quality and surgical treatment among women living in the LHAs of Novara and Verbano Cusio Ossola hospitalized for breast cancer].
Padoan M; Ferrante D; Pretti G; Magnani C
Ig Sanita Pubbl; 2015; 71(2):179-94. PubMed ID: 26057175
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of the impact of the mammography screening program on breast cancer mortality: feasibility study on linking several data sources in North Rhine-Westphalia].
Fuhs A; Bartholomäus S; Heidinger O; Hense HW
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):60-7. PubMed ID: 24357174
[TBL] [Abstract][Full Text] [Related]
32. Development of breast cancer mortality considering the implementation of mammography screening programs - a comparison of western European countries.
Iwamoto Y; Kaucher S; Lorenz E; Bärnighausen T; Winkler V
BMC Public Health; 2019 Jun; 19(1):823. PubMed ID: 31242882
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most influential factors.
Neeser K; Szucs T; Bulliard JL; Bachmann G; Schramm W
Value Health; 2007; 10(1):42-53. PubMed ID: 17261115
[TBL] [Abstract][Full Text] [Related]
34. Results from the Swiss mammography screening pilot programme.
Bulliard JL; De Landtsheer JP; Levi F
Eur J Cancer; 2003 Aug; 39(12):1761-9. PubMed ID: 12888372
[TBL] [Abstract][Full Text] [Related]
35. Breast Cancer Incidence by Stage Before and After Change in Screening Guidelines.
Guo F; Kuo YF; Berenson AB
Am J Prev Med; 2019 Jan; 56(1):100-108. PubMed ID: 30573138
[TBL] [Abstract][Full Text] [Related]
36. [Participation rates in the third round (2006-2007) of the breast cancer screening program in Hungary].
Boncz I; Döbrõssy L; Péntek Z; Kovács A; Budai A; Vajda R; Sebestyén A
Magy Onkol; 2013 Sep; 57(3):140-6. PubMed ID: 24107819
[TBL] [Abstract][Full Text] [Related]
37. Use of Screening Mammography to Detect Occult Malignancy in Autologous Breast Reconstructions: A 15-year Experience.
Noroozian M; Carlson LW; Savage JL; Jeffries DO; Joe AI; Neal CH; Patterson SK; Hadjiiski LM; Helvie MA
Radiology; 2018 Oct; 289(1):39-48. PubMed ID: 30129903
[TBL] [Abstract][Full Text] [Related]
38. Disparities in breast screening, stage at diagnosis, cancer treatment and the subsequent risk of cancer death: a retrospective, matched cohort of aboriginal and non-aboriginal women with breast cancer.
Banham D; Roder D; Keefe D; Farshid G; Eckert M; Howard N; Canuto K; Brown A;
BMC Health Serv Res; 2019 Jun; 19(1):387. PubMed ID: 31200700
[TBL] [Abstract][Full Text] [Related]
39. Mammography screening in Switzerland: limited evidence from limited data.
Zwahlen M; Bopp M; Probst-Hensch NM
Swiss Med Wkly; 2004 May; 134(21-22):295-306. PubMed ID: 15243841
[TBL] [Abstract][Full Text] [Related]
40. Benefits of Organized Mammographic Screening Programs in Women Aged 50 to 69 years: A Surgical Perspective.
Fancellu A; Sanna V; Sedda ML; Delrio D; Cottu P; Spanu A; Giuliani G; Conti M; Piras R; Crivelli P; Porcu A
Clin Breast Cancer; 2019 Oct; 19(5):e637-e642. PubMed ID: 31130366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
